197 related articles for article (PubMed ID: 28946818)
1. Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.
Bavassano C; Eigentler A; Stanika R; Obermair GJ; Boesch S; Dechant G; Nat R
Stem Cells Dev; 2017 Nov; 26(22):1612-1625. PubMed ID: 28946818
[TBL] [Abstract][Full Text] [Related]
2. DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.
Tsou WL; Hosking RR; Burr AA; Sutton JR; Ouyang M; Du X; Gomez CM; Todi SV
Hum Mol Genet; 2015 Aug; 24(15):4385-96. PubMed ID: 25954029
[TBL] [Abstract][Full Text] [Related]
3. Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6.
Pastor PDH; Du X; Fazal S; Davies AN; Gomez CM
Cerebellum; 2018 Feb; 17(1):72-77. PubMed ID: 29374372
[TBL] [Abstract][Full Text] [Related]
4. Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6.
Du X; Wang J; Zhu H; Rinaldo L; Lamar KM; Palmenberg AC; Hansel C; Gomez CM
Cell; 2013 Jul; 154(1):118-33. PubMed ID: 23827678
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar [corrected] Ataxia Type 6: Molecular Mechanisms and Calcium Channel Genetics.
Du X; Gomez CM
Adv Exp Med Biol; 2018; 1049():147-173. PubMed ID: 29427102
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization and ER-mediated cytotoxic function of α1A and α1ACT in spinocerebellar ataxia type 6.
Wang D; Honda S; Shin MK; Watase K; Mizusawa H; Ishikawa K; Shimizu S
Biochem Biophys Res Commun; 2024 Feb; 695():149481. PubMed ID: 38211534
[TBL] [Abstract][Full Text] [Related]
7. Polyglutamine length-dependent toxicity from α1ACT in Drosophila models of spinocerebellar ataxia type 6.
Tsou WL; Qiblawi SH; Hosking RR; Gomez CM; Todi SV
Biol Open; 2016 Dec; 5(12):1770-1775. PubMed ID: 27979829
[TBL] [Abstract][Full Text] [Related]
8. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
Miyazaki Y; Du X; Muramatsu S; Gomez CM
Sci Transl Med; 2016 Jul; 8(347):347ra94. PubMed ID: 27412786
[TBL] [Abstract][Full Text] [Related]
9. The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes.
Restituito S; Thompson RM; Eliet J; Raike RS; Riedl M; Charnet P; Gomez CM
J Neurosci; 2000 Sep; 20(17):6394-403. PubMed ID: 10964945
[TBL] [Abstract][Full Text] [Related]
10. Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs.
Ishida Y; Kawakami H; Kitajima H; Nishiyama A; Sasai Y; Inoue H; Muguruma K
Cell Rep; 2016 Nov; 17(6):1482-1490. PubMed ID: 27806289
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of alpha 1A Ca2+ channel currents arising from expanded trinucleotide repeats in spinocerebellar ataxia type 6.
Piedras-Renteria ES; Watase K; Harata N; Zhuchenko O; Zoghbi HY; Lee CC; Tsien RW
J Neurosci; 2001 Dec; 21(23):9185-93. PubMed ID: 11717352
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
[TBL] [Abstract][Full Text] [Related]
13. Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum.
Takahashi M; Ishikawa K; Sato N; Obayashi M; Niimi Y; Ishiguro T; Yamada M; Toyoshima Y; Takahashi H; Kato T; Takao M; Murayama S; Mori O; Eishi Y; Mizusawa H
Neuropathology; 2012 Dec; 32(6):595-603. PubMed ID: 22393909
[TBL] [Abstract][Full Text] [Related]
14. [Molecular physiopathology of the spinocerebellar ataxia type 6 (SCA6)].
Cervantes-Kardasch VH; García-Martínez E
Rev Invest Clin; 2004; 56(3):368-74. PubMed ID: 15612520
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic cleavage and cellular toxicity of the human alpha1A calcium channel in spinocerebellar ataxia type 6.
Kubodera T; Yokota T; Ohwada K; Ishikawa K; Miura H; Matsuoka T; Mizusawa H
Neurosci Lett; 2003 Apr; 341(1):74-8. PubMed ID: 12676347
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathogenesis of spinocerebellar ataxia type 6.
Kordasiewicz HB; Gomez CM
Neurotherapeutics; 2007 Apr; 4(2):285-94. PubMed ID: 17395139
[TBL] [Abstract][Full Text] [Related]
17. Loss of Flocculus Purkinje Cell Firing Precision Leads to Impaired Gaze Stabilization in a Mouse Model of Spinocerebellar Ataxia Type 6 (SCA6).
Chang HHV; Cook AA; Watt AJ; Cullen KE
Cells; 2022 Sep; 11(17):. PubMed ID: 36078147
[TBL] [Abstract][Full Text] [Related]
18. Early onset, non fluctuating spinocerebellar ataxia and a novel missense mutation in CACNA1A gene.
Tonelli A; D'Angelo MG; Salati R; Villa L; Germinasi C; Frattini T; Meola G; Turconi AC; Bresolin N; Bassi MT
J Neurol Sci; 2006 Feb; 241(1-2):13-7. PubMed ID: 16325861
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of Spinocerebellar Ataxia type 6: glutamine repeat disorder, channelopathy and transcriptional dysregulation. The multifaceted aspects of a single mutation.
Giunti P; Mantuano E; Frontali M; Veneziano L
Front Cell Neurosci; 2015; 9():36. PubMed ID: 25762895
[TBL] [Abstract][Full Text] [Related]
20. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6.
Ishikawa K; Fujigasaki H; Saegusa H; Ohwada K; Fujita T; Iwamoto H; Komatsuzaki Y; Toru S; Toriyama H; Watanabe M; Ohkoshi N; Shoji S; Kanazawa I; Tanabe T; Mizusawa H
Hum Mol Genet; 1999 Jul; 8(7):1185-93. PubMed ID: 10369863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
